Acute Lung Injury Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $3.07 Billion
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Acute Lung Injury Market?
In the past few years, there has been a consistent growth in the market size of acute lung injury. The market, which is expected to be worth $2.48 billion in 2024, is forecast to rise to $2.59 billion in 2025, representing a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the historic period encompass awareness campaigns, a surge in ICU admissions, the prevalence of smoking and air pollution, hospital-induced infections, and initiatives aimed at lessening the mortality rate.
In the coming years, the market size for acute lung injury is predicted to experience consistent growth. It is anticipated to increase to $3.07 billion in 2029, with a compound annual growth rate (CAGR) of 4.3%. Factors contributing to this projected growth during the forecast period include advances in biologics and gene therapies, government-backed funding and grants, the progression of precision medicine, regenerative medicine and stem cell therapies, and international health policy reforms. Key trends during this period are expected to be the creation of biologic drugs, the use of wearable and remote monitoring devices, therapies based on inhalation, the application of CRISPR and gene editing technologies, and the use of biosensors for real-time analysis.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp
What Drivers Are Accelerating Expansion Of The Acute Lung Injury Market?
The anticipated surge in the acute lung injury market can be attributed to the increasing occurrence of respiratory diseases. These encompass a spectrum of conditions affecting the lungs and other components of the respiratory system, which can result in breathing difficulties and compromised lung functionality. The escalating incidence of these diseases can likely be attributed to factors such as air pollution, smoking, inactive lifestyles, aging demographic, and viral infections. Respiratory conditions like pneumonia can trigger acute lung injury by causing intense inflammation and harm to the alveoli, leading to hindered gas exchange and respiratory distress. For instance, data from the Australian Bureau of Statistics, an Australian government agency, disclosed that the mortality rate from influenza and pneumonia witnessed a sharp surge from 31.9 per 100,000 individuals in 2021 to 42.6 per 100,000 individuals in 2022, marking a significant augmentation of roughly 33.54%. Hence, the increasing prevalence of respiratory diseases is expediting the growth of the acute lung injury market.
What Are The Primary Segmentation Parameters In The Acute Lung Injury Market?
The acute lung injurymarket covered in this report is segmented –
1) By Injury Type: Direct Injury; Indirect Injury
2) By Therapy: Mechanical Ventilation; Pharmacotherapy; Fluid Management; Other Therapies
3) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury; Aspiration Pneumonitis; Pneumonia-Related Acute Lung Injury; Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury; Shock-Induced Acute Lung Injury; Acute Lung Injury Due To Blood Transfusion; Acute Lung Injury Associated With Pancreatitis
Which Emerging Trends Are Reshaping The Acute Lung Injury Market Landscape?
Prominent companies in the acute lung injury market are concentrating on the development of innovative therapies, such as peptide therapies, in order to maintain their market share. Peptide therapy refers to the usage of peptide sequences of amino acids as potent healing agents for various health issues. As an instance, in November 2022, Zuventus Healthcare Ltd., a healthcare firm located in India, introduced Aviptadil as a treatment for acute respiratory distress syndrome (ARDS). This treatment has a number of distinct advantages, including highly effective vasodilatory properties that are 50 times more potent than prostacyclin, a mechanism to safeguard the lungs that stimulates surfactant production by binding with alveolar type II cells, anti-inflammatory effects that suppress pro-inflammatory cytokines like IL-6 and TNF-alpha, and an immunomodulatory feature that controls immune reactions in the lungs. Additionally, Aviptadil has demonstrated clinical effectiveness in enhancing the results for patients suffering from severe ARDS caused by viruses.
Which Players Are Shaping The Competitive Landscape Of The Acute Lung Injury Market?
Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report
What Are The Emerging Regional Trends Driving The Acute Lung Injury Market?
North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp
Browse Through More Reports Similar to the Global Acute Lung Injury Market 2025, By The Business Research Company
Lung Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Small Cell Lung Cancer Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
